Avacta establishes US commercial team

By

Sharecast News | 02 Oct, 2017

Updated : 16:00

17:20 03/05/24

  • 45.50
  • -2.15%-1.00
  • Max: 46.50
  • Min: 44.56
  • Volume: 3,142,357
  • MM 200 : 0.68

Affirmer biotherapeutic and reagent developer Avacta Group announced on Monday that it has established a commercial team of three people in the US, including the appointment of Dr Matthew Vincent as vice president therapeutics business development.

Last news

Europe close: Stocks end mixed after 'Goldilocks' US jobs data
London close: Stocks rise as US payrolls come in weaker
U.S. non-farm payroll growth slows to just 175,000 in April
Director dealings: Cohort CEO makes share sale
Week ahead: Bank of England, euro area services PMIs in focus